Matinas Biopharma Holdings, Inc. (MTNB) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Matinas Biopharma Holdings, Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Matinas Biopharma Holdings, Inc. and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.4M and $2.4M). Across the 10 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 7 and Matinas Biopharma Holdings, Inc. on 3.

Valuation

Metric MTNB PPBT Biotechnology median
P/E n/m n/m 7.88
P/S 0.24 n/m 11.47
P/B 0.57 0.13 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.14 0.74
EV/Sales 0.05 n/m 10.73
Earnings yield (731.25%) (3,301.47%) (28.84%)
Free cash flow yield (595.22%) (492.29%) (23.03%)

Profitability

Metric MTNB PPBT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.28%) (110.67%) (57.72%)
Return on assets (98.53%) (100.91%) (49.22%)
Return on invested capital (419.27%) (290.25%) 0.00%

Growth

Metric MTNB PPBT Biotechnology median
Revenue growth (TTM) 2,139.41% — 5.64%
EPS growth (last fiscal year) 59.84% (10.14%) —
Revenue growth, 5-year CAGR 55.69% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.85 3.70 4.73
Net debt to EBITDA 0.62 0.35 0.96

Dividend

Metric MTNB PPBT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MTNB PPBT Biotechnology median
Market cap 2.41m 2.40m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack